Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular DystrophyCarol Wittlieb‐Weber, Jonathan N. Johnson, Shriprasad R. Deshpande et al.|Pediatric Cardiology|2020Cited by 42
Use of advanced heart failure therapies in Duchenne muscular dystrophyCarol Wittlieb‐Weber, Kenneth R. Knecht, Chet Villa et al.|Progress in Pediatric Cardiology|2019Cited by 20
Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular DystrophyKatheryn Gambetta, Carol Wittlieb‐Weber, Michael A. McCulloch et al.|Pediatric Cardiology|2022Cited by 18
Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular DysfunctionMichael A. McCulloch, Carol Wittlieb‐Weber, Ashwin K. Lal et al.|Pediatric Cardiology|2020Cited by 9
Everolimus and Low-Dose Tacrolimus After Heart Transplant in ChildrenChristopher S. Almond, Akanksha Gupta, Kevin P. Daly et al.|JAMA|2025Cited by 4